If not, please take a few moments to fill out the form below. It’s free, and ensures that you receive regular alerts to the latest clinical news and other content.

Keep me logged in Forgot your password?

Please wait...

Please wait...

Bladder Cancer

Bladder Cancer More Likely with Radiotherapy

May 20, 2012

Radiation therapy for prostate cancer (PCa) is associated with a greater likelihood of bladder cancer development compared with radical prostatectomy (RP), Japanese researchers reported at the American Urological Association 2012 annual meeting.
 

Study: Immediate Intravesical Chemotherapy Underused

May 20, 2012

Immediate intravesical chemotherapy (IVC) is underused in bladder cancer patients, according to a presentation at the American Urological Association 2012 annual meeting.
 

Presenting Symptoms May Aid in Initial Bladder Cancer Diagnosis

May 19, 2012

Irritative urinary symptoms are encountered more frequeny among patients with bladder cancer who are exposed to bladder carcinogens as a result of occupational activities, according to a Brazilian study presented at the American Urological Association 2012 annual meeting.
 

Benign Prostatic Hyperplasia

BPH Surgical Approaches Compared

May 19, 2012

Transurethral resection of the prostate (TURP) for the treatment of benign prostatic hyperplasia (BPH) is associated with an increased risk of complications but a significantly lower risk of repeat BPH surgery compared to minimally-invasive surgeries, according to a poster presentation at the American Urological Association 2012 annual meeting.
 

BPH Surgery Complication Rates Underestimated

April 30, 2012

PARIS—Complication rates after surgery for benign prostatic hyperplasia (BPH) are higher in real clinical practice than in clinical trials.
 

Open Prostatectomy, TURP Are the Most Common BPH Surgeries

April 25, 2012

Despite the emergence of new surgical techniques to treat benign prostatic hyperplasia (BPH), open prostatectomy (OP) and monopolar transurethral resection of the prostate (TURP) remain the procedures used most by urologists, according to a recent survey.
 

Erectile Dysfunction

New Erectile Dysfunction Drug Approved

April 30, 2012

Avanafil (Stendra) is the first drug to be approved for the condition in nearly 10 years.
 

Irbesartan May Preserve Erectile Function After RRP

April 10, 2012

Regular irbesartan use after nerve-sparing radical retropubic prostatectomy (RRP) could improve postoperative recovery of erectile function among patients with normal preoperative erectile function, according to researchers.
 

How has your erectile dysfunction caseload changed since PDE-5 inhibitors became commercially available?

March 08, 2012

When phosphodiesterase-5 (PDE-5) inhibitors became commercially available for treating erectile dysfunction (ED), it was speculated that urologists could see a big decline in the number of ED patients.
 

Hypogonadism

New Formulations of Androderm Approved

October 21, 2011

The FDA has approved two lower-dose formulations for Androderm, a once-daily transdermal patch for men with low testosterone.
 

Testosterone Therapy May Not Improve Erectile Dysfunction

October 18, 2011

ORLANDO, Fla.—Testosterone supplementation in elderly men with borderline low testosterone levels may not improve erectile dysfunction (ED) compared with placebo, new findings suggest.
 

Male Hypogonadism Linked to Ratio of Finger Lengths

July 07, 2011

The ratio of the second and fourth finger lengths (2D/4D ratio) may predict which men have testosterone deficiency, researchers reported.
 

Kidney Stones

In pediatric renal stone cases for which either shockwave lithotripsy (SWL) or ureteroscopy would be appropriate, which approach do you prefer?

May 04, 2012

Researchers recently published a study showing that the proportion of pediatric kidney stone cases treated with ureteroscopy has increased significantly relative to the use of SWL.
 

Urology Practice Setting Affects Stone Treatment Choice

May 04, 2012

Shock wave lithotripsy use more common among community practices.
 

Page Kidney Resulting in New Onset Hypertension

, May 01, 2012

A 55-year-old Caucasian woman initially presented to one of Cleveland Clinic's regional outpatient urology clinics with gross hematuria and an obstructing right ureteral stone.
 

Kidney Cancer

Survival Better with Partial Nephrectomy

May 19, 2012

Partial nephrectomy (PN) is associated with better overall survival compared with radical nephrectomy (RN) for patients with early-stage kidney cancer, researchers reported at the American Urological Association 2012 annual meeting.
 

Drug Cleared for Treating Renal Angiomyolipomas

April 27, 2012

The FDA has approved everolimus (Afinitor) for the treatment of renal angiomyolipomas and tuberous sclerosis complex (TSC) in adult kidney tumor patients who do not require immediate surgery.
 

Active Surveillance May Be Okay for Some Men with Metastatic Kidney Cancer

April 27, 2012

Active surveillance may be appropriate for up to 10% of patients with metastatic kidney cancer, according to researchers at the Cleveland Clinic.
 

Overactive Bladder

Oxybutynin Gel Eases Urinary Incontinence

May 21, 2012

A new oxybutynin gel (OTG) with propylene glycol to aid transdermal delivery, which dispensed via a pump, is effective for treating urgency and mixed urinary incontinence (UI), according to the findings of a phase 3 study presented at the American Urological Association 2012 annual meeting.
 

OAB Sufferers Less Physically Active

May 19, 2012

Men and women with overactive bladder (OAB) are significantly less likely to achieve recommended physical activity levels than those with no or minimal symptoms (NMS) of OAB, according to a poster presentation at the American Urological Association 2012 annual meeting.
 

Transdermal Gel for Overactive Bladder Launched

April 27, 2012

Watson Pharmaceuticals of Parsippany, N.J., and Antares Pharma. Inc. of Ewing, NJ, have announced the launch of Gelnique (oxybutynin), a transdermal gel for the treatment of overactive bladder (OAB) with symptoms of urge urinary incontinence, urgency and frequency.
 

Premature Ejaculation

Advance Made on Drug for Premature Ejaculation

September 23, 2011

Investigators think they have arrived at the ideal dosage of tramadol (Zertane) for helping men who suffer from premature ejaculation. This experimental on-demand oral agent may help improve intravaginal ejaculatory latency time with a favorable safety profile.
 

New Medication Helps Men with Premature Ejaculation

July 05, 2011

A promising new agent is safe and effective at improving premature ejaculation (PE). Called Zertane, it may have advantages over current treatments.
 

Acupuncture May Treat Premature Ejaculation

January 28, 2011

Acupuncture may be another treatment option for premature ejaculation (PE), new findings suggest.
 

Prostate Cancer

UTUC Tumor Location Affects Oncologic Outcomes

May 21, 2012

Tumor location independently predicts cancer-specific survival (CSS) and recurrence-free survival (RFS) in patients with upper tract urothelial carcinoma (UTUC), researchers reported at the American Urological Association 2012 annual meeting.
 

Post-RP Survival Unaffected by Early Biochemical Recurrence

May 21, 2012

Early biochemical recurrence after radical prostatectomy (RP) has no effect on survival among patients with low-risk prostate cancer (PCa), according to a study presented at the American Urological Association 2012 annual meeting.
 

HIFU Salvage Following EBRT Offers Good PCa Control

May 21, 2012

High-intensity focused ultrasound (HIFU) provides shows promise as a salvage treatment option men with recurrent prostate cancer (PCa) following external beam radiotherapy (EBRT), data presented at the American Urological Association annual meeting suggest.
 

Prostate Specific Antigen

Cure Possible Despite Positive Lymph Nodes

May 21, 2012

Long-term PSA relapse-free survival after radical prostatectomy (RP) and pelvic lymph node dissection (PLND) is possible in a subset of patients with low volume nodal metastases, a researcher reported at the American Urological Association 2012 annual meeting.
 

Prostate Cancer Screening: Moving Beyond PSA

May 01, 2012

More than 1 million prostate biopsies are performed annually in the United States, predominantly driven by elevations in PSA.
 

After Radical Prostatectomy, Patient Learns He Never Had Prostate Cancer

May 01, 2012

Dr. B, 57, was a urologist with a busy private practice. One of his patients was Mr. O, 69, who had an abnormal PSA result.
 

Reproductive Medicine

Testicular Exams Often Omitted from Physicals

May 20, 2012

More than one quarter of adolescent and adult males aged 15-45 report not having a testicular exam during a routine physical in the previous 12 months as recommended in American Cancer Society guidelines, according to data presented at the American Urological Association 2012 annual meeting.
 

Semen Quality Diminished by Too Much Saturated Fats

May 10, 2012

Diets high in saturated fats may be associated with reduce semen quality, according to researchers at Massachusetts General Hospital.
 

Too Much Fat May Harm Sperm Quality

April 28, 2012

Higher total fat intake was negatively related to total sperm count and concentration in an analysis of data from 99 men.
 

Urinary Incontinence

Oxybutynin Gel Eases Urinary Incontinence

May 21, 2012

A new oxybutynin gel (OTG) with propylene glycol to aid transdermal delivery, which dispensed via a pump, is effective for treating urgency and mixed urinary incontinence (UI), according to the findings of a phase 3 study presented at the American Urological Association 2012 annual meeting.
 

Urinary Incontinence Prevalence Rises with Increasing BMI

May 19, 2012

Increasing body mass index (BMI) is associated with an increased prevalence of urinary incontinence (UI) symptoms, and BMI status varies substantially by gender and UI subgroup, according to results presented at the American Urological Association 2012 annual meeting.
 

Assessment and Diagnostic Strategies for Neurogenic Bladder: Part I

By David A. Ginsberg, MD May 01, 2012

Diagnostics and treatment options for NGB are continually advancing, and clinicians need to remain up-to-date to accurately assess and optimally manage patients
 

Urinary Tract Infections

Microscopic Hematuria a Poor Indicator of Urinary Tract Cancer

May 20, 2012

Microscopic hematuria is an unreliable indicator of urinary tract malignancy, according to study findings presented at the American Urological Association 2012 annual meeting.
 

Urinary E. coli Resistance to Ciprofloxacin, TMP/SMX Growing

May 07, 2012

Study reveals large increase in resistance to ciprofloxacin and TMP-SMX from 2000 to 2010.
 

Assessment and Diagnostic Strategies for Neurogenic Bladder: Part I

By David A. Ginsberg, MD May 01, 2012

Diagnostics and treatment options for NGB are continually advancing, and clinicians need to remain up-to-date to accurately assess and optimally manage patients
 
 Subscribe to the RSS for this page  [view all our RSS feeds here]
Popular Topics
Acute Kidney Injury AKI Androgen Deprivation Anemia Benign Prostatic Hyperplasia Bladder Cancer BPH Cardiovascular Disease Chronic Kidney Disease Circumcision CKD CVD Dialysis End-stage Renal Disease Hemodialysis Overactive Bladder Prostate Cancer Renal Cell Carcinoma Reproductive Medicine Secondary Hyperparathyroidism Transplantation Urinary Incontinence Urinary Tract Infection Urology UTI

 

© 2012 Haymarket Media, Inc.

This material may not be published, broadcast, rewritten or redistributed in any form without prior authorization.

Your use of this website constitutes acceptance of Haymarket Media's Privacy Policy and Terms & Conditions